Fingolimod (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Fingolimod" in French language version.

refsWebsite

Global rank French rank

5nejm.org

2,374^th place

298^th place

4wiley.com

222^nd place

129^th place

1qmul.ac.uk

1,735^th place

168^th place

1nih.gov

4^th place

12^th place

1fasebj.org

low place

1sciencemag.org

857^th place

208^th place

1neurology.org

9,919^th place

3,656^th place

1elsevierhealth.com

low place

1sciencedirect.com

149^th place

80^th place

1thelancet.com

2,393^rd place

506^th place

1ahajournals.org

3,608^th place

659^th place

1confex.com

6,094^th place

6,934^th place

1sagepub.com

731^st place

771^st place

1fda.gov

447^th place

1,409^th place

1sante.fr

8,603^rd place

517^th place

1novartis.com

low place

ahajournals.org

circ.ahajournals.org

Santos-Gallego CG, Vahl TP, Goliasch G et al. Sphingosine-1-Phosphate receptor agonist fingolimod increases myocardial salvage and decreases adverse postinfarction left ventricular remodeling in a porcine model of ischemia/reperfusion, Circulation, 2016;133:954-966

confex.com

cmsc.confex.com

Randhawa, S., Meng, X., & Hashmonay, R. (2013) Cardiac Effects of Fingolimod: First-Dose observation (Poster).

elsevierhealth.com

journals.elsevierhealth.com

(en) Miron VE, Ludwin SK, Darlington PJ et al. « Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices » Am J Pathol, 2010;176:2682-2694.

fasebj.org

(en) Graler MH, Goetzl EJ, « The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors » FASEB J, 2004;18:551-553.

fda.gov

(en) « FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod) », 20 décembre 2011

nejm.org

(en) Kappos L, Antel J, Comi G et al. « Oral fingolimod (FTY720) for relapsing multiple sclerosis » N Engl J Med, 2006;355:1124-1140.
(en) Cohen JA, Barkhof F, Comi G et al. « Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis » N Engl J Med, 2010;362:402-415.
(en) Kappos L, Radue EW, O'Connor P et al. « A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis » N Engl J Med, 2010;362:387-401.
Chitnis T, Arnold DL, Banwell B et al. Trial of fingolimod versus interferon beta-1a in pediatric multiple sclerosis, N Engl J Med, 2018;379:1017-1027
(en) Pelletier D, Hafler DA, « Fingolimod for multiple sclerosis » N Engl J Med, 2012;366:339-347.

neurology.org

(en) Mehling M, Brinkmann V, Antel J et al. « FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis » Neurology, 2008;71:1261-1267.

nih.gov

ncbi.nlm.nih.gov

(en) Adachi K, Chiba K, « FTY720 Story. Its Discovery and the Following Accelerated Development of Sphingosine 1-Phosphate Receptor Agonists as Immunomodulators Based on Reverse Pharmacology » Perspect Medicin Chem, 2007;1:11–23.

novartis.com

(en) Novartis, « Gilenya Information Center », sur novartis.com, 17 août 2015 (consulté le 24 août 2015).

qmul.ac.uk

chem.qmul.ac.uk

Masse molaire calculée d’après « Atomic weights of the elements 2007 », sur www.chem.qmul.ac.uk.

sagepub.com

msj.sagepub.com

(en) Espinosa PS, Berger JR, « Delayed fingolimod-associated asystole » Mult Scler, 2011;17:1387-1389.

sante.fr

ansm.sante.fr

Site de l'Agence nationale de sécurité du médicament et des produits de santé, France, (page consulté le 8 février 2013

sciencedirect.com

(en) Hu Y, Lee X, Ji B et al. « Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivo » Mol Cell Neurosci, 2011;48:72-81.

sciencemag.org

(en) Mandala S, Hajdu R, Bergstrom J et al. « Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists » Science, 2002;296:346-349.

thelancet.com

Lublin F, Miller DH, Freedman MS et al. Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial, Lancet, 2016;387:1075–1084

wiley.com

onlinelibrary.wiley.com

(en) Zhou PJ, Wang H, Shi GH, Wang XH, Shen ZJ, Xu D, « Immunomodulatory drug FTY720 induces regulatory CD4(+)CD25(+) T cells in vitro » Clin Exp Immunol, 2009;157:40-47.
(en) Miron VE, Jung CG, Kim HJ, Kennedy TE, Soliven B, Antel JP, « FTY720 modulates human oligodendrocyte progenitor process extension and survival » Ann Neurol, 2008;63:61-71.
(en) Yamagata K, Tagami M, Torii Y et al. « Sphingosine 1-phosphate induces the production of glial cell line-derived neurotrophic factor and cellular proliferation in astrocytes » Glia, 2003;41:199-206.
(en) Koyrakh L, Roman MI, Brinkmann V, Wickman K, « The heart rate decrease caused by acute FTY720 administration is mediated by the G protein-gated potassium channel I » Am J Transplant, 2005;5:529-536.